No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
MedPlus Health Services Limited is an Indian company primarily focused on healthcare retail and diverse related services. It not only retails pharmaceutical products but also engages in their manufacturing, encompassing a wide range of items such as medicines, nutritional supplements, medical instruments, and diagnostic kits. Beyond health-specific goods, the company distributes fast-moving consumer goods (FMCG), including personal hygiene products, infant care essentials, cleaning agents like soaps and detergents, and sanitizers. MedPlus further diversified its operations by offering bulk distribution (cash and carry), providing comprehensive pathological laboratory testing, and undertaking contract manufacturing for private label pharmaceutical brands. Its extensive retail footprint covers various Indian states, namely Karnataka, Tamil Nadu, Telangana, Andhra Pradesh, West Bengal, Maharashtra, Orissa, and Puducherry, complemented by an active online presence. Established in 2006, the company's headquarters are located in Hyderabad, India.
www.medplusindia.comNo one on the platform currently holds MEDPLUS.BO.
No tracked institution reports a position in MEDPLUS.BO as of their last filing.
No one on the platform has traded MEDPLUS.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.8% | 17.1% | — | — | — | |
| Rev. Growth % | 12.3% | 17.6% | ||||
| Profit Margin % | 3.2% | 2.1% | ||||
| Free Cash Flow Margin % | 5.9% | 2.9% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $80.5B | +17.8% | $17.28 | $15.20–$19.47 | — | 4 |
| 2028 | $92.1B | +14.4% | $26.97 | $17.95–$31.51 | — | 5 |
| 2029 | $105.1B | +14.1% | $35.87 | $28.49–$43.24 | — | 2 |
| 2030 | $117.0B | +11.3% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-21 | $1.95 | $2.80 | +43.6% |
| 2026-05-20 | $5.20 | $5.30 | +1.9% |
| 2026-01-30 | $4.80 | $5.35 | +11.5% |
| 2025-10-31 | $4.15 | $4.60 | +10.8% |
| 2025-08-02 | $2.85 | $3.50 | +22.8% |
| 2025-05-27 | $3.80 | $4.30 | +13.2% |
| 2025-01-31 | $2.70 | $3.80 | +40.7% |
| 2024-11-12 | $1.95 |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| MEDPLUS.BOMedPlus Health Services Limited | $655.25 | -0.81% | $78.7B | — |
| JLHL.BOJupiter Life Line Hospitals Limited | $275.40 | -1.27% | $91.9B | — |
| JLHL.NSJupiter Life Line Hospitals Limited | $275.55 | -1.29% | $90.3B | — |
| METROPOLIS.BOMetropolis Healthcare Limited | $572.30 | -2.25% | $119.1B | — |
| METROPOLIS.NSMetropolis Healthcare Limited |
| $3.20 |
| +64.1% |
| $572.50 |
| -2.22% |
| $118.7B |
| — |
| PGHL.BOProcter & Gamble Health Limited | $5424.40 | +0.36% | $90.2B | — |
| PGHL.NSProcter & Gamble Health Limited | $5408.00 | -0.06% | $89.8B | — |
Source: Financial Modeling Prep · peers by sector/industry